US pharma tariffs would raise US drug costs by $51 billion annually, report finds

Trump’s planned pharmaceutical tariffs would raise costs by $51bn annually

Prices of medication and other costs could increase by as much as 12.9 percent if the tariffs are put in place

Trump pharma tariffs would raise U.S. drug costs by $51 billion annually, report finds

Pharmaceutical Research and Manufacturers of America includes Amgen, Bristol Myers Squibb, Eli Lilly, and Pfizer, among others.

Pharma tariffs could raise prescription drug costs by $51B

Tariffs on pharmaceutical imports could raise U.S. drug prices by $51B annually. Read more here.

US pharma tariffs would raise US drug costs by $51 billion annually, report finds

A 25% U.S. tariff on pharmaceutical imports would increase U.S. drug costs by nearly $51 billion annually, boosting U.S. prices by as much as 12.9% if passed on, a report commissioned by the industry's U.S. trade group and reviewed by Reuters shows.

Pharma tariffs would raise U.S. drug costs by $51 billion annually, report finds

LONDON - A 25% U.S. tariff on pharmaceutical imports would increase U.S. drug costs by nearly $51 billion annually, boosting U.S. prices by as much as 12.9% if passed on, a report commissioned by the industry's U.S. trade group and…

Trump's plans to assess tariffs on imported drugs could raise prices, cause drug shortages

Patients will likely eventually see higher prices and drug shortages under President Trump's plan to assess tariffs on prescription drug imports.